Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • India’s Trusted Labour Law Compliance Partner for 20 Years – Digiliance Business
  • Union Cabinet Minister Ashwini Vaishnav felicitates Young Industrialist Rohit Somani from Indore with Excellence Award Business
  • Environmentalist Viral Desai will develop a school as a model green school in Surat Press Release
  • greytHR Elevates Expense Management Module with AI-Powered, Mobile-First Upgrade Business
  • Eduwisor Aims At Providing 10,000 Doctors To India Over The Next 10 Years Business
  • USI in collaboration with CSC-e-Governance and PCTI to facilitate the military heritage tourism Business
  • Lords Mark Industries Ltd in collaboration with Unnat Bharat Abhiyan inaugurates revolutionary E-Smart Clinic in Wayanad Kerala, advancing Healthcare Accessibility across India Business
  • Annual Event to Commemorate Civilian-Led Peacebuilding in Mindanao Calls Forth Collective Action to Develop Peace Press Release

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • UAE’s Mulk International & Ajeenkya DY Patil Group Partner To Launch Virtual Hospital Worth Dh100m Health
  • Reshaping Women’s Wellness With Advanced Medical Technology Health
  • Meyer Vitabiotics Makes History on World Osteoporosis Day, Secures Spot in Asia Book of Records Health
  • Sankara Eye Foundation, India Unveils First-of-its Kind Innovation Lab for Eye Care in the Country Health
  • Human BioSciences Raises Awareness on Burn Injuries and Life-Saving Solutions Health
  • STAR Hospitals – Celebrating World CPR Day: Stories of Life, Hope, and the Power of Knowledge Health

Recent Posts

  • The House of Makeba Launches O’Vanta, India’s First-of-Its-Kind Interactive, Immersive Dining Experience
  • Century Business Media Limited IPO Opens On 11th September, Sets Price Band At Rs 70 to Rs 74 Per Share
  • Kellton Wins First Prize at SEBI’s Securities Market TechSprint 2026, Turning Regulation into Code with Agentic AI
  • Best Crypto Presale: AlphaPepe Targets 300x Potential as Hunter Meme Coin Plunges From $222 to Below $2
  • Duroply launches DURO HDMMR™ – High Density Max Moisture Resistant Engineered Board

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • A Web 3.0 Product based on Real World Metaverse for gamers seeking sustainable economies Business
  • How to Understand Health Insurance Policy Documents Without Confusion Health
  • Much-needed Maldivian Honeymoon – post-Omicron Lifestyle
  • Celebration of grand festival of “Urja Mahotsav”, from 7th to 12th January 2026 Lifestyle
  • Terrablu and Rentokil Initial Hygiene India Forge Strategic Alliance to Drive Sustainability Transformation in Hygiene Services Business
  • Mr. Sanjeev Kwatra Shares His Thoughts on “The Birth of a Child” and the Need to Eradicate Social Evils Lifestyle
  • Siyaram Recycling Industries Ltd Reports Strong FY25 Results: Net Profit Surges 94% YoY Business
  • VivahSahyog: Redefining the Realm of Love and Marriage in India Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme